The tear layer approach is effective in the diagnosis and treatment of dry eye syndrome.
Modern Medicine Now
Ophthalmologists should not order routine genetic tests for patients with common disorders like age-related macular degeneration until there are specific therapeutic interventions available to treat the disease based on the genetic information.
Topical branded nonsteroidal anti-inflammatory drugs are safe to use in patients with evaporative dry eye syndrome and in those with meibomian gland dysfunction.
Having the ARVO meeting in any of various locations enables the group to accommodate more program options and have a variety of hotel options nearby.
It is vital to identify and prevent dry eye and blepharitis pre-surgery because these conditions can affect IOL calculations and more.
FDA investigators say counterfeit vials of Roche/Genentech's bevacizumab that have turned up in U.S. medical practices for the second time in 2 months have no active ingredient.
The world of glaucoma management in 2012 is feeling the impact of not only a variety of challenges, but also new opportunities.
Many ophthalmologists may be dropping the ball when treating moderate dry eye, which could result in progression to more severe stages of disease.
Tear osmolarity is well correlated to visual function, and may also be a key marker of dry eye disease
Results from randomized controlled clinical trials investigating populations covering the spectrum from ocular hypertension to advanced glaucoma provide clear evidence that for most patients, glaucoma is an IOP-sensitive optic neuropathy for which lowering IOP is effective in slowing or arresting progression.